Increased muscle interstitial levels of inflammatory cytokines in polymyalgia rheumatica

Arthritis Care and Research

Volumn 62, Issue 12, 2010, Pages 3768-3775

  Kreiner, Frederik ^a   Langberg, Henning ^b   Galbo, Henrik ^a  

^a University of Copenhagen   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LACTIC ACID; MONOCYTE CHEMOTACTIC PROTEIN 1; PREDNISOLONE; PYRUVIC ACID; TUMOR NECROSIS FACTOR ALPHA; C REACTIVE PROTEIN; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INTERSTITIUM; MALE; MICRODIALYSIS; MORNING DOSAGE; MUSCLE TISSUE; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; RHEUMATIC POLYMYALGIA; SYMPTOM; TRAPEZIUS MUSCLE; VASTUS LATERALIS MUSCLE; BLOOD LEVEL; DRUG DOSE INCREASE; INTERSTITIAL FLUID; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CHEMOKINE CCL2; CYTOKINES; FEMALE; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; MUSCLE, SKELETAL; POLYMYALGIA RHEUMATICA; PREDNISOLONE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78649815368     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27728     Document Type: Article

References (41)

1. Salvarani C, Cantini F, Boiardi L, Hunder GG,. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002; 347: 261-71.
2. Camellino D, Sambuceti G, Morbelli S, Cimmino MA,. The multifaceted pathogenesis of polymyalgia rheumatica/giant cell arteritis [clinical images]. Arthritis Rheum 2009; 60: 2771.
3. Gordon I, Rennie AM, Branwood AW,. Polymyalgia rheumatica: biopsy studies. Ann Rheum Dis 1964; 23: 447-55.
4. Shintani S, Tsuruoka S, Tamaki M, Mihara N, Shiigai T, Kikuchi M,. Immunofluorescence study of immune complexes in polymyalgia rheumatica. J Neurol Sci 1995; 128: 103-6.
5. Harle JR, Pellissier JF, Desnuelle C, Disdier P, Figarella-Branger D, Weiller PJ,. Polymyalgia rheumatica and mitochondrial myopathy: clinicopathologic and biochemical studies in five cases. Am J Med 1992; 92: 167-72.
6. Miro O, Casademont J, Jarreta D, Grau JM, Urbano-Marquez A, Cardellach F,. Skeletal muscle mitochondrial function in polymyalgia rheumatica and in giant cell arteritis. Rheumatology (Oxford) 1999; 38: 568-71.
7. Mattei JP, Bendahan D, Erkintalo M, Harle JR, Weiller PJ, Roux H, et al. P-31 magnetic resonance spectroscopy demonstrates unaltered muscle energy utilization in polymyalgia rheumatica. Arthritis Rheum 1997; 40: 1817-22.
8. Perez C, Maravi E, Garcia-Bragado F,. Polymyalgia rheumatica as the initial manifestation of skeletal muscle arteritis with giant cells. Muscle Nerve 2001; 24: 1403-4.
9. Marzo-Ortega H, McGonagle D, O'Connor P, Pease C, Emery P,. Subclinical vasculitis in polymyalgia rheumatica. Ann Rheum Dis 2001; 60: 1058-9.
10. Blockmans D, De Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H,. Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients. Rheumatology (Oxford) 2007; 46: 672-7.
11. Chatelain D, Duhaut P, Loire R, Bosshard S, Pellet H, Piette JC, et al. Small-vessel vasculitis surrounding an uninflamed temporal artery: a new diagnostic criterion for polymyalgia rheumatica? Arthritis Rheum 2008; 58: 2565-73.
12. Salvarani C, Barozzi L, Cantini F, Niccoli L, Boiardi L, Valentino M, et al. Cervical interspinous bursitis in active polymyalgia rheumatica. Ann Rheum Dis 2008; 67: 758-61.
13. Macchioni P, Catanoso MG, Pipitone N, Boiardi L, Salvarani C,. Longitudinal examination with shoulder ultrasound of patients with polymyalgia rheumatica. Rheumatology (Oxford) 2009; 48: 1566-9.
14. Meliconi R, Pulsatelli L, Uguccioni M, Salvarani C, Macchioni P, Melchiorri C, et al. Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica: quantitative analysis and influence of corticosteroid treatment. Arthritis Rheum 1996; 39: 1199-207.
15. Healey LA,. Polymyalgia rheumatica is the result of synovitis. J Clin Rheumatol 2006; 12: 165-6.
16. Cantini F, Niccoli L, Nannini C, Padula A, Olivieri I, Boiardi L, et al. Inflammatory changes of hip synovial structures in polymyalgia rheumatica. Clin Exp Rheumatol 2005; 23: 462-8.
17. Lonnroth P, Jansson PA, Smith U,. A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol 1987; 253: E228-31.
18. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT,. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 1982; 97: 672-80.
19. Langberg H, Skovgaard D, Petersen LJ, Bulow J, Kjaer M,. Type I collagen synthesis and degradation in peritendinous tissue after exercise determined by microdialysis in humans. J Physiol 1999; 521 Pt 1: 299-306.
20. Scheller D, Kolb J,. The internal reference technique in microdialysis: a practical approach to monitoring dialysis efficiency and to calculating tissue concentration from dialysate samples. J Neurosci Methods 1991; 40: 31-8.
21. 2O. J Appl Physiol 1999; 86: 1054-61.
22. Clausen TS, Kaastrup P, Stallknecht B,. Proinflammatory tissue response and recovery of adipokines during 4 days of subcutaneous large-pore microdialysis. J Pharmacol Toxicol Methods 2009; 60: 281-7.
23. De Jager W, Rijkers GT,. Solid-phase and bead-based cytokine immunoassay: a comparison. Methods 2006; 38: 294-303.
24. Uceyler N, Schafers M, Sommer C,. Mode of action of cytokines on nociceptive neurons. Exp Brain Res 2009; 196: 67-78.
25. Hotamisligil GS,. Inflammation and metabolic disorders. Nature 2006; 444: 860-7.
26. Kreiner F, Galbo H,. Insulin sensitivity and related cytokines, chemokines and adipokines in polymyalgia rheumatica. Scand J Rheumatol 2010. E-pub ahead of print.
27. Roche NE, Fulbright JW, Wagner AD, Hunder GG, Goronzy JJ, Weyand CM,. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 1993; 36: 1286-94.
28. Uddhammar A, Sundqvist KG, Ellis B, Rantapaa-Dahlqvist S,. Cytokines and adhesion molecules in patients with polymyalgia rheumatica. Br J Rheumatol 1998; 37: 766-9.
29. Cutolo M, Montecucco CM, Cavagna L, Caporali R, Capellino S, Montagna P, et al. Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis. Ann Rheum Dis 2006; 65: 1438-43.
30. Smolen JS, Beaulieu A, Rubbert-Roth A, Ramos-Remus C, Rovensky J, Alecock E, et al. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet 2008; 371: 987-97.
31. Martinez-Taboada VM, Alvarez L, RuizSoto M, Marin-Vidalled MJ, Lopez-Hoyos M,. Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and implications for treatment. Cytokine 2008; 44: 207-20.
32. Ellingsen T, Elling P, Olson A, Elling H, Baandrup U, Matsushima K, et al. Monocyte chemoattractant protein 1 (MCP-1) in temporal arteritis and polymyalgia rheumatica. Ann Rheum Dis 2000; 59: 775-80.
33. Pulsatelli L, Meliconi R, Boiardi L, Macchioni P, Salvarani C, Facchini A,. Elevated serum concentrations of the chemokine RANTES in patients with polymyalgia rheumatica. Clin Exp Rheumatol 1998; 16: 263-8.
34. Grundtman C, Salomonsson S, Dorph C, Bruton J, Andersson U, Lundberg IE,. Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies. Arthritis Rheum 2007; 56: 674-87.
35. Verri WA, Jr, Cunha TM, Parada CA, Poole S, Cunha FQ, Ferreira SH,. Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development? Pharmacol Ther 2006; 112: 116-38.
36. Shah JP, Danoff JV, Desai MJ, Parikh S, Nakamura LY, Phillips TM, et al. Biochemicals associated with pain and inflammation are elevated in sites near to and remote from active myofascial trigger points. Arch Phys Med Rehabil 2008; 89: 16-23.
37. Salvarani C, Pipitone N, Boiardi L, Hunder GG,. Do we need treatment with tumour necrosis factor blockers for giant cell arteritis? Ann Rheum Dis 2008; 67: 577-9.
38. De Rossi M, Bernasconi P, Baggi F, de Waal Malefyt R, Mantegazza R,. Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation. Int Immunol 2000; 12: 1329-35.
39. Rosendal L, Sogaard K, Kjaer M, Sjogaard G, Langberg H, Kristiansen J,. Increase in interstitial interleukin-6 of human skeletal muscle with repetitive low-force exercise. J Appl Physiol 2005; 98: 477-81.
40. Langberg H, Olesen JL, Gemmer C, Kjaer M,. Substantial elevation of interleukin-6 concentration in peritendinous tissue, in contrast to muscle, following prolonged exercise in humans. J Physiol 2002; 542: 985-90.
41. Akerstrom T, Steensberg A, Keller P, Keller C, Penkowa M, Pedersen BK,. Exercise induces interleukin-8 expression in human skeletal muscle. J Physiol 2005; 563: 507-16.